Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
4
44%
Ph phase_2
3
33%
Ph phase_4
2
22%

Phase Distribution

4

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
4(44.4%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (44.4%)
Phase 23 (33.3%)
Phase 42 (22.2%)

Trials by Status

unknown444%
completed333%
not_yet_recruiting111%
withdrawn111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9